Skip to main content
Premium Trial:

Request an Annual Quote

Fielding Questions on 23andMe and Lifestyle, GINA, Snickering, and More

Readers at the New York Times' Freakonomics blog have grilled 23andMe's Anne Wojcicki. There, she discusses the impact of genetic testing on people's lifestyle, GINA, epigenetics, and why genetic counselors "snicker" at 23andMe. For the last, Wojcicki says that the medical community in the past has been reluctant to shift to "individual empowerment" (she cites over-the-counter pregnancy tests and anonymous HIV tests) and that people can handle knowing their genetic information. "Individuals with access to their APOE allele (which is strongly correlated with age of onset of Alzheimer's) are quite capable of handling that information in a healthy way," she says.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.